Investing in the prevention and treatment of non-communicable diseases (NCDs) can strengthen health systems, protect economic productivity, and improve population wellbeing.
Evidence shows that every dollar invested in preventing and managing NCDs generates substantial returns through reduced healthcare costs, improved workforce participation, and healthier, more resilient societies. Yet despite this compelling investment case, progress remains uneven.
Health systems continue to struggle with the rising burden of cardiovascular, metabolic, renal, chronic respiratory, cancer, and mental health conditions—diseases that now affect nearly two billion people globally and remain the leading cause of premature death. The Political Declaration on NCDs and Mental Health adopted by the UN General Assembly calls for urgency.
A new report from Charles River Associates (CRA) focuses on how to unleash investment in NCDs. Through real world case studies, it documents case studies illustrating the investment associated with NCDs and how barriers preventing investment can be overcome. The research also identifies the policy conditions that enable success; and outlines practical recommendations to scale financing models that work and can be replicated across different countries.
Read more about leveraging the opportunities from investing in noncommunicable diseases here.
